ChariotMS is recruiting 200 patients in the UK who lack mobility due to multiple sclerosis for a new clinical trial.
A new study will investigate the effects of exercise and eating a Mediterranean style diet has on the development of dementia, and whether a change in lifestyle has neuroprotective properties. Researchers are looking for volunteers between 55 and 74 years of age to participate in the study.
Advances in machine learning could allow researchers to detect drug effects that may be missed through conventional statistical analysis, researchers report.
Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule stabilizing agent, for the treatment of Alzheimer’s disease, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).
A clinical trial is being conducted to assess the effectiveness of a cholesterol lowering drug in the treatment of Parkinson's disease.
A new treatment developed to help clear tau tangles in Alzheimer's disease is entering into early stage clinical trials.
A drug currently in phase 3 of trials appears to slow the progression of mild Alzheimer's disease.
A new study claims clinical trials for neurological diseases often fail because the animal studies which preceded them were poorly designed or biased in their interpretation.
Foundation Fighting Blindness and Mass. Eye and Ear Host June 1 Optogenetics Workshop to Fast-Track Innovative Approaches to Save and...
